4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-001158
Chief Business Officer sold 6,945 shares at $26.32 ($182,795)
- Chief Business Officer acquired 6,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parrish Jay · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 1 in the form | +6,945 | $1.49 | $10,313 | 229,167 | D |
| 2021-01-04 | Sale : show line 2 in the form | −6,945 | $26.32 | $182,795 | 222,222 | D |
| Open-market sales · 6,945 sh · avg $26.32 · $182,795 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −6,945 | 16,203 | D |
Loading xslF345X03/doc4.xml…